Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
WISP1 encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. Additionally we are shipping WISP1 Kits (40) and WISP1 Proteins (17) and many more products for this protein.
Showing 10 out of 90 products:
Human Polyclonal WISP1 Primary Antibody for EIA, IHC (p) - ABIN358745
Hocevar, Mou, Rennolds, Morris, Cooper, Howe: Regulation of the Wnt signaling pathway by disabled-2 (Dab2). in The EMBO journal 2003
Show all 5 references for ABIN358745
Human Polyclonal WISP1 Primary Antibody for IHC (p), WB - ABIN390187
Su, Overholtzer, Besser, Levine: WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. in Genes & development 2002
Show all 4 references for ABIN390187
Human Polyclonal WISP1 Primary Antibody for WB - ABIN374896
Major, Camp, Berndt, Yi, Goldenberg, Hubbert, Biechele, Gingras, Zheng, Maccoss, Angers, Moon: Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. in Science (New York, N.Y.) 2007
Human Polyclonal WISP1 Primary Antibody for IF (p), IHC (p) - ABIN872843
Xu, Zhao, Zhang, Xu, Yang, Wang, Liu: Resveratrol Attenuates Hyperoxia-induced Oxidative Stress, Inflammation and Fibrosis and Suppresses Wnt/β-catenin Signaling in Lungs of Neonatal Rats. in Clinical and experimental pharmacology & physiology 2015
Two paralogs of mammalian wisp1 genes were found in zebrafish.
WISP1 plays an important role in regulating proliferation and apoptosis of Jurkat cells.
Study showed that DNA methylation (show HELLS Antibodies) of the WISP1 promoter in the majority of the oral squamous cell carcinoma explains its expression regulation.
CCN4 has a positive influence on chondrogenic differentiation by modulating the effects of TGF-beta3 (show TGFB3 Antibodies).
Studies indicate that the CYR61 (show CYR61 Antibodies) CTGF (show CTGF Antibodies) NOV (show NOV Antibodies) matricellular proteins (CCN family of proteins) comprises the members CCN1 (show CCNA2 Antibodies), CCN2 (show CTGF Antibodies), CCN3 (show NOV Antibodies), CCN4, CCN5 (show WISP2 Antibodies) and CCN6 (show WISP3 Antibodies) and have been identified in various types of cancer.
Its role in tumor progression and clinical outcome makes WISP1 an emerging candidate for the detection and treatment of tumors. [review]
WISP1 contributed to radioresistance primarily by repressing irradiation-induced DNA damage and activating PI3K (show PIK3CA Antibodies) kinase.
WISP1 functions as an oncogene (show RAB1A Antibodies) for human breast cancer. Ectopic expression of WISP1 in breast cancer cells promotes cell growth and metastasis.
This study suggests that osteoblast-derived WISP-1 promotes migration and VCAM-1 (show VCAM1 Antibodies) expression in human prostate cancer cells by down-regulating miR (show MLXIP Antibodies)-126 expression
WISP1 polymorphisms (rs2929965, rs2929969, rs2929970, rs2929973 and rs754958) were related to the overall platinum-based chemotherapy toxicity of lung cancer in subgroup analyses.
Our data indicate that WISP-1 plays an important role in the development of radioresistance in esophageal cancer cells during fractionated irradiation.
the Bmp3 (show BMP3 Antibodies)/Wisp1 signaling pathway play a key role in mesenchymal stem cell proliferation, and consequently adipogenesis.
the Wisp1-integrin beta6 pathway is inhibited by RGD peptides in septic mice, which protects against acute lung injury
WISP1 is a novel regulator of bone turnover and Wnt (show WNT2 Antibodies) signaling
The data suggest that WISP1 may play a role in linking obesity to inflammation and insulin (show INS Antibodies) resistance and could be a novel therapeutic target for obesity.
Wnt5a (show WNT5A Antibodies)-induced Wnt1 (show WNT1 Antibodies)-inducible secreted protein-1 suppresses vascular smooth muscle cell apoptosis induced by oxidative stress.
Notch1 (show NOTCH1 Antibodies)-induced WISP-1 expression appeared to be Wnt11 (show WNT11 Antibodies)-dependent, but Wnt1 (show WNT1 Antibodies)-independent
WISP-1 exerts paracrine action on immune cells by inhibiting their response to IL12 (show IL12A Antibodies)
WISP1 is an endogenous signal that acts through TLR4 (show TLR4 Antibodies) signaling to increase alveolar-capillary permeability in ventilator-induced lung injury.
WISP-1 has a positive influence on bone cell differentiation and function and may work by enhancing the effects of BMP-2 (show BMP2 Antibodies)
This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like domain. This gene may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. It is expressed at a high level in fibroblast cells, and overexpressed in colon tumors. The encoded protein binds to decorin and biglycan, two members of a family of small leucine-rich proteoglycans present in the extracellular matrix of connective tissue, and possibly prevents the inhibitory activity of decorin and biglycan in tumor cell proliferation. It also attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. It is 83% identical to the mouse protein at the amino acid level. Multiple alternatively spliced transcript variants have been identified.
WNT1 inducible signaling pathway protein 1
, CCN family member 4
, WNT1 induced secreted protein 1
, WNT1-inducible-signaling pathway protein 1
, Wnt-1 inducible signaling pathway protein 1
, Wnt-1-induced secreted protein